SabaSabirShaikhMD

PubMed

• 1 citations
  Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy f...
  Austin D Williams, Karen Ruth, Saba S Shaikh, Mahtab Vasigh, Mary T Pronovost, Allison A Aggon, Andrea S Porpiglia, Richard J Bleicher> ;Cancer. 2024 Apr 1
• 5 citations
  Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
  Mohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, Jack L Arbiser, Elizabeth G Berry, Julide T Celebi, Clara Curiel-Lewandrowski, Laura K Ferris, Jane M Grant...> ;JAMA Dermatology. 2023 May 1
• 5 citations
  A retrospective analysis of the impact of the COVID-19 pandemic on staging at presentation of patients with invasive melanoma.
  Saba S Shaikh, Xi Yang, Dylan D Fortman, Hong Wang, Diwakar Davar, Jason J Luke, Hassane Zarour, John M Kirkwood, Yana G Najjar> ;Journal of the American Academy of Dermatology. 2022 Oct 1
• 2 citations
  Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma.
  Saba S Shaikh, Yan Zang, Janel Hanmer, Hong Wang, Yan Lin, Diwakar Davar, Hassane M Zarour, John M Kirkwood, Yana G Najjar> ;Frontiers in Oncology. 2022 Jan 1
• 7 citations
  Current and emerging biologic therapies for triple negative breast cancer
  Saba Shaikh, Leisha A. Emens> ;Expert Opinion on Biological Therapy. 2020 Aug 9
• Join now to see all